Amisulpride in dysthymia: Results of a naturalistic study in general practice

European Psychiatry

Volumn 11, Issue SUPPL. 3, 1996, Pages 145s-147s

  Paes De Sousa, M ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

amisulpride; benzamide; dysthymia; general practice; treatment

Indexed keywords

AMISULPRIDE;

ADULT; AGED; ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERANCE; DYSTHYMIA; FEMALE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0343898216     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-9338(96)85190-X     Document Type: Article

References (14)

1. Boyer P, Lecrubier Y, Puech A et al. Treatment of dysthymia with low doses of amisulpride vs amineptine. Clin Neuropharmacol 1992;15(1B):23
2. Deniker P, Ginestet D. Neuroleptiques. In: Encycl Méd-Chir Psychiatrie. 37860 B20. Paris: Elsevier, 1973
3. Gekière F, Roger B, Soret C, Borenstein P. Biological tolerance of amisulpride with long-term treatment. In: Borenstein et al eds. Amisulpride. Paris: Expansion Scientifique Française, 1989:181-7
4. Gessa G. Dysthymia and depressive disorders: dopamine hypothesis. Eur Psychiatry 1996:this issue
5. Jenner P, Marsden CD. Substituted benzamide drugs as selective neuroleptic agents. Neuropharmacology 1981;20, 1285-93
6. Lecrubier Y, Puech A, Simon P, Widlocher D. Schizophrénie: hyper ou hypofonctionnement du système dopaminergique? Une hypothèse bipolaire. Psychologie Méd 1980;12: 2431-41
7. Lecrubier Y, Puech AJ, Aubin F, Boyer P, Deyrieux B. Improvement by amisulpride of the negative syndrome in non-psychotic subjects. A preliminary study. Psychiatry Psychobiol 1988; 3(5):329-33
8. Lecrubier Y, Puech AJ, Boyer P. The Contribution of Neuropharmacology to the Understanding of Ill-Defined Psychological Disorders. In: Sartorius N, Goldberg D, de Girolamo G, Costa e Silva JA, Lecrubier Y, Wittchen, eds. Psychological Disorders in General Medical Settings. New York: Hogrefe & Huber Publishers, 1990;98-110
9. Protais P, Hermier C, Costentin J. The discriminant dopamine antagonist property of benzamides is observed at various times after their systemic or intracerebroventricular administration. Neuropharmacology 1985;24:861-7
10. Puech A, Simon P, Boissier JR. Benzamides and classical neuroleptics. Comparison of their action using 6-apomorphine- induced effects. Eur J Pharmacol 1978;50:291-300
11. Sedvall C, Alfredsson G, Bjerkenstedt L, Harnryd C, Oxenstierna G, Wiesel FA. Clinical, biochemical and pharmacokinetic studies of sulpiride in schizophrenic patients. In: Ackenheil M, Matussek M, eds. Special aspects of psychopharmacology. Paris: Expansion Scientifique Française, 1983;153-70
12. Sheehan DV. The anxiety disease. New York: Scribner and Sons, 1983
13. 4) identified by binding studies with 3H-apomorphine and 3H-domperidone. Naunyn-Schmiedeberg's Arch Pharmacol 1990;315: 89-102
14. WPA Dysthymia Working Group. Dysthymia in clinical practice. Br J Psychiatry 1995;166:174-83